
脂肪素/(±)-维拉帕米。盐酸(USP级)/AG-CR1-3627-G005/5 g
商品编号:
AG-CR1-3627-G005
品牌:
Adipogen Inc
市场价:
¥1800.00
美元价:
1080.00
产品分类:
其他试剂
公司分类:
Other_reagents
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
ProductDetails | |
---|---|
Synonyms | NSC135784;NSC272366;NSC657799 |
ProductType | Chemical |
Properties | |
Formula | C27H38N2O4.HCl |
MW | 454.6.36.5 |
CAS | 152-11-4 |
RTECS | YV8320000 |
Source/HostChemicals | Synthetic. |
PurityChemicals | ≥99%(NMR) |
Appearance | Whitepowder. |
Solubility | Solubleinmethanol(50mg/ml),ethanolorwater. |
InChiKey | DOQPXTMNIUCOSY-UHFFFAOYSA-N |
ShippingandHandling | |
Shipping | AMBIENT |
ShortTermStorage | +4°C |
LongTermStorage | +4°C |
HandlingAdvice | Keepcoolanddry. Protectfromlightandmoisture. |
Use/StABIlity | Stableforatleast2yearsafterreceiptwhenstoredat+4°C. |
Documents | |
MSDS | ![]() |
ProductSpecificationSheet | |
Datasheet | ![]() |
- α1-Adrenergicreceptor(α-AR)antagoNIST.
- PrototypicalcalciumchannelproteininhibitorthatblockstheL-typeCa2+channelsinsmoothandcardiacmusclecells.
- Vasodilatorknowntoreducetherenalclearanceofdigoxinandusedtocontrolhypertension,angina,cardiacarrhythmiaandvascularheadaches.
- Apoptosisinducerinprimaryandmetastaticcolonadenocarcinomahumancelllinesinvitro.
- InhibitorofdrugeffluxpumpproteinssuchasMdr(P-glycoprotein)whichareoftenover-expressedincertaintumorcelllines.
- SubstrateofCYP3A4andCYP2C6.
- UsedinfluorescentcellsortingforDNAcontent,asitblockseffluxofavarietyofDNA-bindingfluorophoressuchasHoechst33342.
- Anti-diabeticinanimalmodelsbylimitingTXNIPexpression.
ProductReferences
- Newantiarrhythmicagents:amiodarone,aprindine,disopyramide,ethmozin,mexiletine,tocainide,verapamil:D.P.Zipes&P.J.Troup;Am.J.Cardiol.41,1005(1978)(Review)
- alpha-adrenergicantagonistsaspossIBLecalciumchannelinhibitors:D.Atlas&M.Adler;PNAS78,1237(1981)
- Verapamilhydrochloride:pharmacologicalpropertiesandroleincardiovasculartherapeutics:S.H.Baky&B.N.Singh;Pharmacotherapy2,328(1982)(Review)
- Verapamil:fullspectrumcalciumchannelblockingagent:anoverview:J.R.Guerrero&S.S.Martin;Med.Res.Rev.4,87(1984)(Review)
- Thecalciumchannelblockerverapamilandcancerchemotherapy:W.G.Simpson;CellCalcium6,449(1985)(Review)
- Themechanismofactionofcalciumantagonistsrelativetotheirclinicalapplications:B.N.Singh;Br.J.Clin.Pharmacol.21,109S(1986)
- Enhancementofthemutagenicityofanticancerdrugsbythecalciumantagonistsverapamilandfendiline:W.Scheid,etal.;Arzneimittelforschung41,901(1991)(Review)
- Apoptosisofhumanprimaryandmetastaticcolonadenocarcinomacelllinesinvitroinducedby5-fluorouracil,verapamil,andhyperthermia:I.B.Shchepotin,etal.;AnticancerRes.14,1027(1994)
- ReversalofanovelmultidrugresistancemechanisminhumancoloncarcinomacellsbyfumitremorginC:S.K.Rabindran,etal.;CancerRes.58,5850(1998)
- Erythromycinandverapamilconsiderablyincreaseserumsimvastatinandsimvastatinacidconcentrations:T.Kantola,etal.;Clin.Pharmacol.Ther.64,177(1998)
- P-glycoproteinsystemasadeterminantofdruginteractions:thecaseofdigoxin-verapamil:M.Verschraagen,etal.;Pharmacol.Res.40,301(1999)
- Preventingβ-celllossanddiabeteswithcalciumchannelblockers:G.Xu,etal.;Diabetes61,848(2012)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。
联络我们